{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:26:00Z","timestamp":1792621560118,"version":"4.5.0"},"reference-count":47,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2001,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            There is little information about the clinical effectiveness of cefepime and piperacillin-tazobactam in the treatment of infections caused by extended-spectrum \u03b2-lactamase (ESBL)-producing pathogens. Some inferences have been drawn from laboratory studies, which have usually involved only one or a few strains of ESBL-producing\n            <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n            or\n            <jats:italic>Escherichia coli<\/jats:italic>\n            that produced only a limited range of ESBLs. Such studies are indirect, sometimes conflicting, indicators of efficacy. To extend previous laboratory findings, a study was designed to investigate organism-drug interactions by determining the in vitro activities of eight parenteral \u03b2-lactam agents against 82 clinical and laboratory strains of\n            <jats:italic>Klebsiella<\/jats:italic>\n            ,\n            <jats:italic>Escherichia<\/jats:italic>\n            ,\n            <jats:italic>Enterobacter<\/jats:italic>\n            ,\n            <jats:italic>Citrobacter<\/jats:italic>\n            ,\n            <jats:italic>Serratia<\/jats:italic>\n            ,\n            <jats:italic>Morganella<\/jats:italic>\n            , and\n            <jats:italic>Proteus<\/jats:italic>\n            species that produced 22 different ESBLs, alone or in combination with other \u03b2-lactamases. Activities were determined in broth microdilution MIC tests using standard and 100-fold-higher inocula. An inoculum effect, defined as an eightfold or greater MIC increase on testing with the higher inoculum, was most consistently detected with cefepime, cefotaxime, and ceftriaxone and least frequently detected with meropenem and cefoteten. Piperacillin-tazobactam was intermediate between these two groups of agents. Although the inoculum effect is an in vitro laboratory phenomenon, if it has any predictive value in identifying increased risk of therapeutic failure in serious infections, these results support suggestions that cefepime may be a less-than-reliable agent for therapy of infections caused by ESBL-producing strains.\n          <\/jats:p>","DOI":"10.1128\/aac.45.12.3548-3554.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:06:42Z","timestamp":1027764402000},"page":"3548-3554","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":201,"title":["Cefepime, Piperacillin-Tazobactam, and the Inoculum Effect in Tests with Extended-Spectrum \u03b2-Lactamase-Producing\n            <i>Enterobacteriaceae<\/i>"],"prefix":"10.1128","volume":"45","author":[{"given":"Kenneth S.","family":"Thomson","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Center for Research in Antiinfectives and Biotechnology, Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska 68178"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen Smith","family":"Moland","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Center for Research in Antiinfectives and Biotechnology, Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska 68178"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01647010"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01968060"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.4.761"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.2.308"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90891-9"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1211"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.11.1915"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.11.3177-3179.2000"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/35.1.7"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.2.358-363.1996"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.5.858"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.9.1697"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/10.4.867"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.5.1187"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/37.1.203"},{"key":"e_1_3_2_17_2","unstructured":"Korzeniowski\n              O.\n              Kaye\n              D.\n          Endocarditis\n          Infectious diseases\n          2nd ed.\n              Gorbach\n              S. L.\n              Bartlett\n              J. G.\n              Blacklow\n              N. R.\n          1998\n          663\n          674\n          W. B. Saunders Company\n          Philadelphia Pa"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.2.195"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/41.suppl_4.25"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.7.1669"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-88-1-169"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.9.1883"},{"key":"e_1_3_2_23_2","unstructured":"National Committee for Clinical Laboratory Standards\n          Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4.\n          1997\n          National Committee for Clinical Laboratory Standards\n          Villanova Pa"},{"key":"e_1_3_2_24_2","unstructured":"National Committee for Clinical Laboratory Standards\n          Performance standards for antimicrobial susceptibility testing; tenth informational supplement (aerobic dilution) M100-S10.\n          2000\n          NCCLS\n          Wayne Pa"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.3.566"},{"key":"e_1_3_2_26_2","first-page":"57","article-title":"Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins.","volume":"8","author":"O'Callaghan C. H.","year":"1968","unstructured":"O'Callaghan C. H. Muggleton P. W. Ross G. W. Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins. Antimicrob. Agents Chemother. 8 1968 57 63","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2000.00107.x"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.6.2206-2212.2001"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/517217"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.1.1"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01650727"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2000.00002.x"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.11.2663"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.1.118"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.11.2193"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.3.403"},{"key":"e_1_3_2_37_2","unstructured":"Sambrook\n              J.\n              Fritsch\n              E. F.\n              Maniatis\n              T.\n          Molecular cloning: a laboratory manual\n          2nd ed.\n          1989\n          Cold Spring Harbor Laboratory Press\n          Cold Spring Harbor N.Y"},{"key":"e_1_3_2_38_2","first-page":"369","article-title":"Cefepime: the next generation?","volume":"17","author":"Sanders C. C.","year":"1993","unstructured":"Sanders C. C. Cefepime: the next generation? Clin. Infect. Dis. 17 1993 369 379","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_39_2","first-page":"57","article-title":"In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases.","volume":"8","author":"Sanders C. C.","year":"1996","unstructured":"Sanders C. C. In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases. J. Chemother. 8 (Suppl. 2) 1996 57 62","journal-title":"J. Chemother."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.6.951"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/36.suppl_A.19"},{"key":"e_1_3_2_42_2","unstructured":"Stratton\n              C. W.\n          In vitro testing: correlations between bacterial susceptibility body fluid levels and effectiveness of antibacterial therapy\n          Antibiotics in laboratory medicine\n          3rd ed.\n              Lorian\n              V.\n          1991\n          849\n          879\n          Williams & Wilkins\n          Baltimore Md"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/2.2.115"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.5.1053"},{"key":"e_1_3_2_45_2","first-page":"151","article-title":"Novel plasmid-mediated \u03b2-lactamases in Enterobacteriaceae: emerging problems for new \u03b2-lactam antibiotics","volume":"16","author":"Thomson K. S.","year":"1996","unstructured":"Thomson K. S. Prevan A. M. Sanders C. C. Novel plasmid-mediated \u03b2-lactamases in Enterobacteriaceae: emerging problems for new \u03b2-lactam antibiotics Current clinical topics in infectious diseases Remington J. S. Swartz M. N. 16 1996 151 163 Blackwell Science, Inc. Cambridge, Mass","journal-title":"Current clinical topics in infectious diseases"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(00)01276-4"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01713572"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.4.915"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.12.3548-3554.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.12.3548-3554.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:02:13Z","timestamp":1645462933000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.45.12.3548-3554.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["10.1128\/AAC.45.12.3548-3554.2001"],"URL":"https:\/\/doi.org\/10.1128\/aac.45.12.3548-3554.2001","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]},"assertion":[{"value":"2001-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-08-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}